PRECIGEN, INC. — Director's Dealing 2015

Jun 1, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2015-05-28

Reporting Person: Frost Gregory Ian (SVP--Health Sector)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-28	Common Stock	M	200000	$22.77	Acquired	300000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-28	Option to Purchase Common Stock (Right to Buy)	$22.77	M	200000	Disposed	2024-01-06	Common Stock (200000)	Direct

Footnotes

F1: At the time of exercise, 250,000 options held by the reporting person were vested. After exercise, 50,000 options held by the reporting person remain vested, and the remaining 750,000 options vest annually in increments of 250,000 per year on each of January 6, 2016, 2017 and 2018.